NCT04302454
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04302454
Title Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy (ADOPT)
Acronym ADOPT
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors University Medical Center Groningen
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD


No variant requirements are available.